Name	KVG	Anteil am ETF
L&G Pharma Breakthrough UCITS ETF USD Acc. WKN A2H9XR · ISIN IE00BF0H7608	Legal & General	2,40 %
Xtrackers Nordic Net Zero Pathway Paris Aligned UCITS ETF 1C EUR Acc. WKN DBX0TL · ISIN IE000HT7E0B1	DWS	2,36 %

Zugehörige Fonds zur Genmab Aktie

Name	KVG	Anteil am Fonds
Baillie Gifford Worldwide Health Innovation Fund - A EUR ACC WKN A2QGSX · ISIN IE00BN7HTK74	Baillie Gifford Investment Management (Europe) Limited	5,67 %
Baillie Gifford Worldwide Health Innovation Fund - B USD ACC WKN A2PZED · ISIN IE00BGGJJ945	Baillie Gifford Investment Management (Europe) Limited	5,67 %
Baillie Gifford Worldwide Health Innovation Fund - B EUR ACC WKN A2PZEE · ISIN IE00BGGJJB67	Baillie Gifford Investment Management (Europe) Limited	5,67 %
Baillie Gifford Worldwide Health Innovation Fund - A USD ACC WKN A2P00G · ISIN IE00BKMG4D66	Baillie Gifford Investment Management (Europe) Limited	5,67 %
UBS (Lux) Equity Fund - Biotech (USD) - Q EUR ACC WKN A2JDLA · ISIN LU1769088235	UBS	4,35 %
UBS (Lux) Equity Fund - Biotech (USD) - Q ACC WKN A1J7MJ · ISIN LU0400035332	UBS	4,35 %
UBS (Lux) Equity Fund - Biotech (USD) - P SEK ACC WKN A2PJ5A · ISIN LU1991432631	UBS	4,35 %
UBS (Lux) Equity Fund - Biotech (USD) - QL ACC WKN A2QBCD · ISIN LU2208649280	UBS	4,35 %
UBS (Lux) Equity Fund - Biotech (USD) - P ACC WKN 986327 · ISIN LU0069152568	UBS	4,35 %